InsiderTrades

Form 4 for MOH MOLINA HEALTHCARE, INC.

Accepted 2026-03-02 00:00:00 ET · period of report 2026-03-01 · accession 0001267043-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2026-03-02 2026-03-01 MOH HEBERT MAURICE CAO F - Tax $154.05 -501 11.6K -4% -$77.2K
M 2026-03-02 2026-03-01 MOH HEBERT MAURICE CAO A - Grant $147.74 +2,708 11.9K +30% +$400.1K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-01 F D 272 $154.05 11,357 D — — (F4) The shares were applied to the payment of withholding taxes arising in connection with the vesting of 802 shares on March 1, 2026. (F2) Represents the closing price of the Issuer's common stock on February 27, 2026.
2 Common Common Stock 2026-03-01 F D 229 $154.05 11,629 D — — (F3) The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units. (F2) Represents the closing price of the Issuer's common stock on February 27, 2026.
3 Common Common Stock 2026-03-01 A A 2,058 $145.75 13,415 D — — (F5) Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan. (F6) Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date. (F7) The shares shall vest as follows: The 2,058 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 559 shares on March 1, 2027; and 300 shares on March 1, 2028. The remaining shares are vested.
4 Common Common Stock 2026-03-01 A A 650 $154.05 11,858 D — — (F1) Shares issued in settlement of performance stock units granted on March 1, 2023, based on the Company's achievement of three-year average adjusted earnings per share, at 89% vesting level. (F2) Represents the closing price of the Issuer's common stock on February 27, 2026.